Insidious development of pulmonary embolism in asymptomatic patients with COVID-19: Two rare case-reports | Zendy

Abdulrahman Alharthy | Zendy; Abdullah Balhamar | Zendy; Fahad Faqihi | Zendy; Rayan Alshaya | Zendy; Alfateh Noor | Zendy; Feisal Alaklobi | Zendy; Ziad A. Memish | Zendy; Dimitrios Karakitsos | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Insidious development of pulmonary embolism in asymptomatic patients with COVID-19: Two rare case-reports

Author(s) -

Abdulrahman Alharthy,

Abdullah Balhamar,

Fahad Faqihi,

Rayan Alshaya,

Alfateh Noor,

Feisal Alaklobi,

Ziad A. Memish,

Dimitrios Karakitsos

Publication year - 2020

Publication title -

respiratory medicine case reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.42

H-Index - 14

ISSN - 2213-0071

DOI - 10.1016/j.rmcr.2020.101186

Subject(s) - asymptomatic , medicine , covid-19 , pulmonary embolism , intensive care medicine , disease , asymptomatic carrier , thromboembolic disease , thrombosis , pathology , infectious disease (medical specialty) , outbreak

Scarce data exist regarding the clinical sequelae of COVID-19 and/or the prevalence of thromboembolic disease in asymptomatic patients. Surely, there is increased prevalence of thromboembolic disease and pulmonary embolism (PE) in critically ill patients with COVID-19; hence the administration of even enhanced thromboprophylaxis was suggested. However, the administration of regular thromboprophylaxis in asymptomatic outpatients is an entirely different matter. Herein, we present the clinical story of insidious PE development in two asymptomatic COVID-19 female patients. Issues regarding the pathogenesis of thromboembolism in COVID-19 and the clinical management are equally discussed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research